Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics
Main Authors: Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://ncbi.nlm.nih.gov/pubmed/32053962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020146
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items